Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

10.72USD
4:00pm EDT
Change (% chg)

$0.04 (+0.37%)
Prev Close
$10.68
Open
$10.64
Day's High
$10.80
Day's Low
$10.34
Volume
45,222
Avg. Vol
50,742
52-wk High
$25.50
52-wk Low
$10.34

Select another date:

Thu, Aug 23 2018

Photo

FDA approves Kala Pharma's eye pain drug

The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

U.S. FDA approves Kala Pharma's eye pain drug

Aug 23 The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share Of $0.46

* KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Kala Pharmaceuticals - PDUFA Target Action Date For Inveltys Is August 24, 2018

* KALA PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:

BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46

* KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: